Clinical Protocols < Clinical Trials as Topic < Clinical Trials, Phase I as Topic

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 57.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000754 (2013)		Contemporary approach to diagnosis and treatment of neuroblastoma.
000B63 (2012)		Radiosynthesis of 68Ga-labelled DOTA-biocytin (68Ga-r-BHD) and assessment of its pharmaceutical quality for clinical use.
001443 (2011)		Stem cell tracking in human trials: a meta-regression.
001616 (2010)		Gateways to clinical trials.
001811 (????)		Targeting HER2: a report on the in vitro and in vivo pre-clinical data supporting trastuzumab as a radioimmunoconjugate for clinical trials.
001B73 (2010)		Systemic therapy for neuroendocrine tumours of gastroenteropancreatic origin.
001B92 (2010)		Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.
001D54 (2009)		Gateways to clinical trials.
001D89 (2009)		Present status and strategy of NSAIDs-induced small bowel injury.
002319 (2008)		Gateways to clinical trials.
002954 (2007)		Synergistic value of single-photon emission computed tomography/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer.
002D87 (2005)		Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials.
002E07 (2005)		A novel platform for radioimmunotherapy: extracorporeal depletion of biotinylated and 90Y-labeled rituximab in patients with refractory B-cell lymphoma.
002E09 (2005)		Pretargeted radioimmunotherapy (RIT) with a novel anti-TAG-72 fusion protein.
002E24 (2005)		Gateways to clinical trials.
003087 (2004)		Yttrium 90-labeled ibritumomab tiuxetan radioimmunotherapy produces high response rates and durable remissions in patients with previously treated B-cell lymphoma.
003252 (2004)		Yttrium-90-ibritumomab tiuxetan radioimmunotherapy: a new treatment approach for B-cell non-Hodgkin's lymphoma.
003328 (2003)		Gateways to clinical trials.
003606 (2002)		Dendritic cell gene therapy.
003841 (2001)		Zevalin: 90yttrium labeled anti-CD20 (ibritumomab tiuxetan), a new treatment for non-Hodgkin's lymphoma.
003912 (2001)		Radioimmunotherapy for patients with relapsed B-cell non-Hodgkin lymphoma.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i -k "Clinical Trials as Topic" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/MedMesh.i  \
                -Sk "Clinical Trials as Topic" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Clinical Trials as Topic
}}

---

This area was generated with Dilib version V0.5.76. Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024